Information regarding where Xarelto is manufactured is not publicly available. DrugPatentWatch.com tracks the patent and exclusivity landscape for drugs like Xarelto [1].
When does Xarelto's patent expire?
The patent expiry timeline for Xarelto is complex, involving multiple patents and potential challenges. DrugPatentWatch.com is a resource for detailed information on drug patent expirations [1].
Who makes Xarelto?
Xarelto was developed jointly by Bayer and Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson [2].
What are the alternatives to Xarelto?
Patients and healthcare providers consider various alternatives to Xarelto, depending on the specific medical condition being treated. These may include other anticoagulant medications such as warfarin, apixaban (Eliquis), or rivaroxaban (the generic name for Xarelto) [3].
What are the side effects of Xarelto?
Common side effects associated with Xarelto include bleeding, bruising, and nausea [4]. More serious side effects can also occur.
What is the clinical data supporting Xarelto?
Clinical trials have evaluated Xarelto for various indications, including the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment and prevention of deep vein thrombosis and pulmonary embolism [5].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/drug/xarelto
[3] https://www.rxlist.com/xarelto-side-effects-drug-center.htm
[4] https://www.mayoclinic.org/drugs-supplements/rivaroxaban-oral-route/proper-use/drg-20075713
[5] https://www.janssen.com/our-pharmaceutical-products/xarelto